Table 3.

Outcomes

	TSH	fT3	fT4
Discharge outcomes
Death in hospital		NS	NS
Died	0.5245 (0.303–0.761)*
Alive	1.275 (0.75–1.9875)*
Death in hospital or hospice vs alive	NS		NS
Death or hospice		1.99 (1.74–2.475)*
Alive		2.47 (2.13–2.95)*
3 month outcomes
Death vs alive at 3 months		NS	NS
Death	0.66 (0.372–1.45)*
Alive	1.27 (0.75–2.11)*
Independence level	NS		NS
mBI > 15, independent		2.53 (2.24–2.99)**
mBI < 14, dependent		2.06 (1.85–2.6)**
Poor outcome, mRS > 3 or death	0.873 (0.586–1.48)*
Favourable outcome, mRS < 2	1.54 (0.6575–2.255)*
12 month outcomes
mRS score	NS	R = −0.268*	NS
mBI > 15, independent		2.525 (2.26–2.965)*
mBI < 14, dependent		2.175 (1.865–2.823)*
Poor outcome, mRS > 3 or death		2.04 (1.825–2.485)***
Favourable outcome, mRS < 2		2.62 (2.32–2.97)***

Patients with better acute and long term outcomes had higher TSH levels, and higher fT3 levels at 3 and 12 months post-stroke. No associations were seen between acute and long term outcomes with fT4

*p < 0.05; **p < 0.01; ***p < 0.001